OKE
48
6
FCX
49
-4
MMM
52
2
KO
39
-13
CHD
24
-11
RHI
10
-5
MTCH
48
4
WHR
57
7
FDX
51
4
USB
48
-2
EXPE
58
2
DHI
29
2
MMC
53
2
PFG
40
6
DG
40
-2
EMC
56
-7
CCI
33
3
AAPL
42
3
SYF
72
3
EFX
43
2
OKE
48
6
FCX
49
-4
MMM
52
2
KO
39
-13
CHD
24
-11
RHI
10
-5
MTCH
48
4
WHR
57
7
FDX
51
4
USB
48
-2
EXPE
58
2
DHI
29
2
MMC
53
2
PFG
40
6
DG
40
-2
EMC
56
-7
CCI
33
3
AAPL
42
3
SYF
72
3
EFX
43
2
Financhill
Back

Brighthouse Financial Vs. Blueprint Medicines Industry Stock Comparison

Sell
37

BHF
Brighthouse Financial

Last Price:
$58.84
Seasonality Move:
3.43%
Buy
52

BPMC
Blueprint Medicines

Last Price:
$128.14
Seasonality Move:
10.35%
Sell
37
Brighthouse Financial (BHF) is a Sell

Is Brighthouse Financial a Buy, Sell or Hold?

  • The current Brighthouse Financial [BHF] share price is $58.86. The Score for BHF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BHF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.20. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BHF Stock Price Chart

What is Brighthouse Financial's stock price today?

  • The Brighthouse Financial share price today is $58.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BHF is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

BHF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 52.71 Buy
Chaikin Money Flow: -682833 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.79 - 60.07) Sell
Bollinger Bands (100): (53.52 - 60.8) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.7 Buy
Relative Strength Index (14 RSI): 75.62 Buy
Chaikin Money Flow: 1502050 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (102.43 - 129.61) Buy
Bollinger Bands (100): (85.02 - 113.84) Buy

BHF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.01 Buy
20-day SMA: 58.6 Buy
50-day SMA: 56.81 Buy
200-day SMA: 52.42 Buy
8-day EMA: 58.39 Buy
20-day EMA: 58.39 Buy
50-day EMA: 57.6 Buy
200-day EMA: 53.71 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.11 Buy
20-day SMA: 119.69 Buy
50-day SMA: 103.32 Buy
200-day SMA: 95.92 Buy
8-day EMA: 127.3 Buy
20-day EMA: 120.82 Buy
50-day EMA: 109.36 Buy
200-day EMA: 98.18 Buy

Brighthouse Financial Earnings Growth & BHF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.47 per share, an increase next quarter of $0.57 per share, a decrease this year of $1.56 per share, and an increase next year of $2.48 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Brighthouse Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):